These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 38094870)

  • 1. Role of Gut Microbiota, Immune Imbalance, and Allostatic Load in the Occurrence and Development of Diabetic Kidney Disease.
    Han YZ; Zheng HJ; Du BX; Zhang Y; Zhu XY; Li J; Wang YX; Liu WJ
    J Diabetes Res; 2023; 2023():8871677. PubMed ID: 38094870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease.
    Ma L; Zhang L; Li J; Zhang X; Xie Y; Li X; Yang B; Yang H
    Mol Med; 2023 Oct; 29(1):148. PubMed ID: 37907885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease.
    Mao ZH; Gao ZX; Liu DW; Liu ZS; Wu P
    Front Immunol; 2023; 14():1124704. PubMed ID: 36742307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review.
    Das S; Devi Rajeswari V; Venkatraman G; Elumalai R; Dhanasekaran S; Ramanathan G
    Transl Res; 2024 Mar; 265():71-87. PubMed ID: 37952771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals.
    Han S; Chen M; Cheng P; Zhang Z; Lu Y; Xu Y; Wang Y
    Front Endocrinol (Lausanne); 2022; 13():1018093. PubMed ID: 36339429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective.
    Das S; Gnanasambandan R
    Life Sci; 2023 Mar; 316():121414. PubMed ID: 36682521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease.
    Tao P; Ji J; Wang Q; Cui M; Cao M; Xu Y
    Front Immunol; 2022; 13():1080456. PubMed ID: 36601125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice.
    Wang P; Guo R; Bai X; Cui W; Zhang Y; Li H; Shang J; Zhao Z
    Front Endocrinol (Lausanne); 2022; 13():1034818. PubMed ID: 36589853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intestinal Microbiota Composition in Early and Late Stages of Diabetic Kidney Disease.
    Zhang L; Lu QY; Wu H; Cheng YL; Kang J; Xu ZG
    Microbiol Spectr; 2023 Aug; 11(4):e0038223. PubMed ID: 37341590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota profiling reflects the renal dysfunction and psychological distress in patients with diabetic kidney disease.
    Li Q; Xie S; Liu Y; Yue W; Wang L; Liang Y; Chen Y; Yuan H; Yu J
    Front Endocrinol (Lausanne); 2024; 15():1410295. PubMed ID: 39076512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression.
    Mosterd CM; Kanbay M; van den Born BJH; van Raalte DH; Rampanelli E
    Best Pract Res Clin Endocrinol Metab; 2021 May; 35(3):101484. PubMed ID: 33546983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease.
    Zaky A; Glastras SJ; Wong MYW; Pollock CA; Saad S
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases-A Systematic Review and Meta-Analysis.
    Wang Y; Zhao J; Qin Y; Yu Z; Zhang Y; Ning X; Sun S
    Front Immunol; 2022; 13():908219. PubMed ID: 35784273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moutan Cortex polysaccharide ameliorates diabetic kidney disease via modulating gut microbiota dynamically in rats.
    Zhang M; Yang L; Zhu M; Yang B; Yang Y; Jia X; Feng L
    Int J Biol Macromol; 2022 May; 206():849-860. PubMed ID: 35307460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of Gut Microbial Metabolites in Diabetic Kidney Disease.
    Fang Q; Liu N; Zheng B; Guo F; Zeng X; Huang X; Ouyang D
    Front Endocrinol (Lausanne); 2021; 12():636175. PubMed ID: 34093430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice.
    Wu J; Chen Y; Yang H; Gu L; Ni Z; Mou S; Shen J; Che X
    Front Endocrinol (Lausanne); 2023; 14():1026040. PubMed ID: 36777358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism disorder in diabetic kidney disease.
    Han YZ; Du BX; Zhu XY; Wang YZ; Zheng HJ; Liu WJ
    Front Endocrinol (Lausanne); 2024; 15():1336402. PubMed ID: 38742197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane vesicles derived from gut microbiota mediate tubulointerstitial inflammation: a potential new mechanism for diabetic kidney disease.
    Chen PP; Zhang JX; Li XQ; Li L; Wu QY; Liu L; Wang GH; Ruan XZ; Ma KL
    Theranostics; 2023; 13(12):3988-4003. PubMed ID: 37554279
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.
    Li L; Wei T; Liu S; Wang C; Zhao M; Feng Y; Ma L; Lu Y; Fu P; Liu J
    J Cell Mol Med; 2021 Jan; 25(2):960-974. PubMed ID: 33280239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage polarization and signaling in diabetic kidney disease: a catalyst for disease progression.
    Youssef N; Noureldein MH; Riachi ME; Haddad A; Eid AA
    Am J Physiol Renal Physiol; 2024 Mar; 326(3):F301-F312. PubMed ID: 38153850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.